Why invest

We develop products and solutions that make life better – and have been successfully doing so for over 300 years. And when you’ve prospered for centuries as we have, you must have done a few things right.


It’s a great idea to invest in us – and here’s why

Related News

View All News
  1. Information

    MilliporeSigma Awards Grant to Combined Therapeutics for its Nucleic Acid Platform ...

    MilliporeSigma today announced that Combined Therapeutics Inc., Cambridge, Massachusetts, has been selected as the North American winner of its 2020 Advance Biotech Grant Program

    2020/10/19

  2. Press Releases

    Merck KGaA, Darmstadt, Germany, Announces Retirement of Luciano Rossetti, Global ...

    Merck KGaA, Darmstadt, Germany today announced that Dr. Luciano Rossetti, MD, will be retiring as Global Head of Research & Development (R&D) for the Healthcare business sector.

    2020/10/15

  3. Information

    MilliporeSigma’s New VirusExpress™ Platform Speeds Development of Cell and ...

    MilliporeSigma has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform

    2020/10/13

Investors Shareprice2 Investors Shareprice2
Share Price
Check Share Price
Share Price

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Investors Financials Investors Financials
Financials
Read More
Financials

Our Financial Reporting Center offers you the opportunity to select from financial data on an annual or quarterly basis.

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Internet Explorer is not supported

You are using an outdated browser. If you would like to use our website, please use Chrome, Firefox, Safari or other browser

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement